Filter posts

Good Public Policy Key to Stable Biotech Investment Climate

It is an important and exciting time for the biotechnology industry. Science is galloping forward …

Fireside Chat with Dr. Kim of Inovio Pharmaceuticals: Immunotherapies and Vaccines

The first Fireside Chat at the 2017 BIO CEO & Investor Conference was with President …

Session Recap: Applying Microbiome Research to Therapeutics

The BIO CEO & Investor Conference kicked off Monday with a panel discussion exploring how …

Biopharma Takes Aim at Opioid Abuse

Next-generation painkillers in development are non-addictive One in three Americans – roughly 100 million people …

Coming Down the Pipeline: Patent Cases to Watch in 2017

The Supreme Court returns from recess on February 17, and alongside the likely confirmation of …

Curing Cancer: Advancements and What is Yet to Come

  Last month, MIT Technology Review reported “Two Infants Treated with Universal Immune Cells Have …